MoonLake Immunotherapeutics (MLTX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-1.1
-0.94
-0.79
-0.63

Details

Expected EPS
-0.9882
Actual EPS
N/A
Surprise EPS
0.99
Surprise Percent
+100%

Description

MoonLake Immunotherapeutics (MLTX) will report earnings of for Q1 2026 on February 26, 2026.

0 Comments

Share your thoughts